Find Altrenogest manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 850-52-2, Allyltrenbolone, Regumate, Allyl trenbolone, Ru-2267, A-35957
Molecular Formula
C21H26O2
Molecular Weight
310.4  g/mol
InChI Key
VWAUPFMBXBWEQY-ANULTFPQSA-N
FDA UNII
2U0X0JA2NB

Altrenogest
Altrenogest, also known as allyltrenbolone, is a steroidal progestin that is widely used in veterinary medicine to suppress estrus in animals.
1 2D Structure

Altrenogest

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2.1.2 InChI
InChI=1S/C21H26O2/c1-3-10-21(23)12-9-19-18-6-4-14-13-15(22)5-7-16(14)17(18)8-11-20(19,21)2/h3,8,11,13,18-19,23H,1,4-7,9-10,12H2,2H3/t18-,19+,20+,21+/m1/s1
2.1.3 InChI Key
VWAUPFMBXBWEQY-ANULTFPQSA-N
2.1.4 Canonical SMILES
CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O
2.1.5 Isomeric SMILES
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC=C)O
2.2 Other Identifiers
2.2.1 UNII
2U0X0JA2NB
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 17 Alpha-allyl-17-beta-hydroxyestra-4,9,11-trien-3-one

2. 17 Alpha-allyl-estratriene 4,9,11,17 Beta-ol-one

3. 17-allyltrenbolone

4. Allyl Trenbolone

5. Regumate

6. Ru-2267

2.3.2 Depositor-Supplied Synonyms

1. 850-52-2

2. Allyltrenbolone

3. Regumate

4. Allyl Trenbolone

5. Ru-2267

6. A-35957

7. 2u0x0ja2nb

8. Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propenyl)-, (17b)-

9. Nsc-759180

10. 17-alpha-allyl-estratriene-4,9,11,17-beta-ol-3-one

11. Dsstox_cid_28789

12. Dsstox_rid_83058

13. Dsstox_gsid_48863

14. (8s,13s,14s,17r)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,13,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthren-3-one

15. (8s,13s,14s,17r)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

16. Altrenogestum

17. (17beta)-17-hydroxy-17-(2-propenyl)estra-4,9,11-trien-3-one

18. Cas-850-52-2

19. Regu-mate

20. Drc 6246

21. Unii-2u0x0ja2nb

22. Altrenogestum [inn-latin]

23. Ru 2267

24. Altrenogestrel

25. Altrenogest [usan:inn:ban]

26. R 2267

27. Ncgc00183119-01

28. A 35957

29. Einecs 212-703-1

30. Altrenogest [mi]

31. Altrenogest [inn]

32. Altrenogest (usan/inn)

33. Altrenogest [usan]

34. Altrenogest [mart.]

35. Schembl140056

36. 17alpha-allyl-17-hydroxyestra-4,9,11-trien-3-one

37. Altrenogest [green Book]

38. Chembl1315492

39. Dtxsid3048863

40. Chebi:191255

41. Hms3715d18

42. Bcp13100

43. Drc-6246

44. Estra-4,9,11-trien-3-one, 17beta-hydroxy-17-(2-propenyl)-

45. Hy-b0521

46. Zinc4214784

47. Tox21_113356

48. Mfcd00867855

49. Ru2267

50. S3167

51. Akos025310098

52. Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propen-1-yl)-, (17beta)-

53. Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propenyl)-, (17-beta)-

54. Tox21_113356_1

55. Ccg-221218

56. Db11372

57. Nsc 759180

58. Rh-2267

59. Ncgc00166309-01

60. Ncgc00166309-02

61. As-12848

62. Altrenogest 100 Microg/ml In Acetonitrile

63. A35957;allyltrenbolone;r2267;ru2267

64. B1503

65. R2267

66. A35957

67. D02840

68. Ab01566827_01

69. Altrenogest, Vetranal(tm), Analytical Standard

70. 850a522

71. A841082

72. Q-101420

73. Q4736979

74. (17?)-17-allyl-17-hydroxyestra-4,9,11-trien-3-one

75. 17-alpha-allyl-17-beta-hydroxyestra-4,9,11-trien-3-one

76. 17.alpha.-allyl-17-hydroxyestra-4,9,11-trien-3-one

77. Estra-4,9,11-trien-3-one, 17-alpha-allyl-17-hydroxy-

78. 17.alpha.-allyl-estra-4,9,11-triene-17.beta.-ol-3-one

79. Estra-4,9,11-trien-3-one, 17.beta.-hydroxy-17-(2-propenyl)-

80. Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propen-1-yl)-, (17.beta.)-

81. (8s,13r,14s,17r)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

82. (8s,13s,14s,17r)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;altrenogest

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 310.4 g/mol
Molecular Formula C21H26O2
XLogP32.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass310.193280068 g/mol
Monoisotopic Mass310.193280068 g/mol
Topological Polar Surface Area37.3 Ų
Heavy Atom Count23
Formal Charge0
Complexity665
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Progestins

Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)


Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Altrenogest Manufacturers

A Altrenogest manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Altrenogest, including repackagers and relabelers. The FDA regulates Altrenogest manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Altrenogest API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Altrenogest manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Altrenogest Suppliers

A Altrenogest supplier is an individual or a company that provides Altrenogest active pharmaceutical ingredient (API) or Altrenogest finished formulations upon request. The Altrenogest suppliers may include Altrenogest API manufacturers, exporters, distributors and traders.

click here to find a list of Altrenogest suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Altrenogest USDMF

A Altrenogest DMF (Drug Master File) is a document detailing the whole manufacturing process of Altrenogest active pharmaceutical ingredient (API) in detail. Different forms of Altrenogest DMFs exist exist since differing nations have different regulations, such as Altrenogest USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Altrenogest DMF submitted to regulatory agencies in the US is known as a USDMF. Altrenogest USDMF includes data on Altrenogest's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Altrenogest USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Altrenogest suppliers with USDMF on PharmaCompass.

Altrenogest NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Altrenogest as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Altrenogest API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Altrenogest as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Altrenogest and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Altrenogest NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Altrenogest suppliers with NDC on PharmaCompass.

Altrenogest GMP

Altrenogest Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Altrenogest GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Altrenogest GMP manufacturer or Altrenogest GMP API supplier for your needs.

Altrenogest CoA

A Altrenogest CoA (Certificate of Analysis) is a formal document that attests to Altrenogest's compliance with Altrenogest specifications and serves as a tool for batch-level quality control.

Altrenogest CoA mostly includes findings from lab analyses of a specific batch. For each Altrenogest CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Altrenogest may be tested according to a variety of international standards, such as European Pharmacopoeia (Altrenogest EP), Altrenogest JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Altrenogest USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty